AVE

33.3%

0.2¢ avecho biotechnology limited

Ann: Phosphagenics - February 2016 Newsletter, page-40

First 40 Last

Share
Profile

Follow
turps

8,604 Posts.

83

19/02/16

13:13

Post #: 17064845
Share
Originally posted by hottod ↑

Some points from this morning’s Conference Call.

The projected cash runway was questioned. Murdoch asserts that there is sufficient cash for 2 years, based on current income levels and cost reductions achieved. Nonetheless, he said he also had “expectation” of deals in the medium term.

Murdoch was insistent that the TPM/oxycodone patch trial results were well received by several parties and that more than one party had expressed willingness to partner the topical patch’s next trial. Although he said that “further development and licensing discussions” were continuing, Murdoch could provide no guidance on timeframes nor guarantees.

It was made clear that POH’s contract with Mylan remains intact. Arbitration set down for later this year concerns compensation for alleged breaches of that contract.

TPM diclo gel is said not to have “fallen off the radar”. The company is still in discussion with respect to both increasing volume of sales in India and selling in other countries.

Murdoch appeared to confirm that the sale of BioElixia had been hampered by the ProPhase arbitration. He commented that the company would “re-engage” on sale discussions after the arbitration decision was delivered.

Don’t expect cash inflow via the IAH/Brinicombe deal any time soon. Advice is that European approvals re TPM are needed and would take up to 2 years to achieve.

Regarding directors buying shares – Murdoch said possible windows of opportunity for directors to trade is discussed at each Board meeting. He said that legal opinion has been that there has been no available window of opportunity since the last AGM.

Expand

.so we just find out that European TPM approval is going to take up to two years?...this is insane..the deal was signed nearly a year ago!

from the Feedmate website

..UK trials are now underway and Feed-Mate is also being used on a selected number of commercial dairy units in order to gather data and confirm efficacy in the UK and Irish dairy herd. It will be go on commercial sale in summer 2016 with a planned awareness campaign throughout the feed industry.

poh...please explain?????
POH Price at posting: 1.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

VMT

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Is oil undervalued?

NXG

Cost blow-out for Rook I uranium project sees share plummet for NexGen

BOE

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

GRX

GreenX picks up prospective copper project in Germany

VMS

Venture to sniff out high-grade REE targets at Jupiter project, WA

WGX

Westgold sets its sights on top five producer status through merger with Karora

MGU

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

DVP

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

There are more pages in this discussion • 24 more messages in this thread...

First 40 Last

Add AVE (ASX) to my watchlist

(20min delay)
Last 0.2¢		Change -0.001(33.3%)		Mkt cap ! $6.338M

Open	High	Low	Value	Volume
0.2¢	0.3¢	0.2¢	$16.54K	5.758M

Buyers (Bids)

No.	Vol.	Price($)
59	96791453	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	58594028	16

View Market Depth

No.	Vol.	Price($)
59	96791453	0.002
23	74000508	0.001
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.003	58594028	16
0.004	22905524	20
0.005	20469333	10
0.006	20865067	11
0.007	10865221	9

Last trade - 16.10pm 02/08/2024 (20 minute delay)

AVE (ASX) Chart

Ann: Phosphagenics - February 2016 Newsletter, page-40

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Is oil undervalued?

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

GreenX picks up prospective copper project in Germany

Venture to sniff out high-grade REE targets at Jupiter project, WA

Westgold sets its sights on top five producer status through merger with Karora

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Phosphagenics - February 2016 Newsletter, page-40

Top Stories

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Is oil undervalued?

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

GreenX picks up prospective copper project in Germany

Venture to sniff out high-grade REE targets at Jupiter project, WA

Westgold sets its sights on top five producer status through merger with Karora

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News